384 related articles for article (PubMed ID: 22300735)
21. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
[TBL] [Abstract][Full Text] [Related]
22. Association of Epstein Barr virus A73 gene polymorphism with nasopharyngeal carcinoma.
Shen JJ; Niu WN; Zhou M; Zhou F; Zhang HY; Wang L
Genet Test Mol Biomarkers; 2015 Apr; 19(4):187-90. PubMed ID: 25275219
[TBL] [Abstract][Full Text] [Related]
23. Genetic and epigenetic landscape of nasopharyngeal carcinoma.
Dai W; Zheng H; Cheung AK; Lung ML
Chin Clin Oncol; 2016 Apr; 5(2):16. PubMed ID: 27121876
[TBL] [Abstract][Full Text] [Related]
24. Identification of genomic alterations in nasopharyngeal carcinoma and nasopharyngeal carcinoma-derived Epstein-Barr virus by whole-genome sequencing.
Tu C; Zeng Z; Qi P; Li X; Guo C; Xiong F; Xiang B; Zhou M; Liao Q; Yu J; Li Y; Li X; Li G; Xiong W
Carcinogenesis; 2018 Dec; 39(12):1517-1528. PubMed ID: 30102338
[TBL] [Abstract][Full Text] [Related]
25. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility of circulating Epstein-Barr virus DNA analysis for the management of nasopharyngeal carcinoma.
Fung SY; Lam JW; Chan KC
Chin Clin Oncol; 2016 Apr; 5(2):18. PubMed ID: 27121878
[TBL] [Abstract][Full Text] [Related]
27. Integrated analysis of the differential cellular and EBV miRNA expression profiles in microdissected nasopharyngeal carcinoma and non-cancerous nasopharyngeal tissues.
Wan XX; Yi H; Qu JQ; He QY; Xiao ZQ
Oncol Rep; 2015 Nov; 34(5):2585-601. PubMed ID: 26330189
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.
Sousa H; Mesquita L; Ribeiro J; Catarino R; Breda E; Medeiros R
Immunobiology; 2016 Feb; 221(2):145-52. PubMed ID: 26391153
[TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus infection and nasopharyngeal carcinoma.
Tsao SW; Tsang CM; Lo KW
Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
[TBL] [Abstract][Full Text] [Related]
30. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
[TBL] [Abstract][Full Text] [Related]
31. A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.
Feng FT; Cui Q; Liu WS; Guo YM; Feng QS; Chen LZ; Xu M; Luo B; Li DJ; Hu LF; Middeldorp JM; Ramayanti O; Tao Q; Cao SM; Jia WH; Bei JX; Zeng YX
Chin J Cancer; 2015 Dec; 34(12):563-72. PubMed ID: 26675171
[TBL] [Abstract][Full Text] [Related]
32. Genetic factors leading to chronic Epstein-Barr virus infection and nasopharyngeal carcinoma in South East China: study design, methods and feasibility.
Guo XC; Scott K; Liu Y; Dean M; David V; Nelson GW; Johnson RC; Dilks HH; Lautenberger J; Kessing B; Martenson J; Guan L; Sun S; Deng H; Zheng Y; de The G; Liao J; Zeng Y; O'Brien SJ; Winkler CA
Hum Genomics; 2006 Jun; 2(6):365-75. PubMed ID: 16848974
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Rare and Common Variants from Suspected Familial or Sporadic Nasopharyngeal Carcinoma (NPC) Susceptibility Genes in Sporadic NPC.
Liu Z; Goldstein AM; Hsu WL; Yu KJ; Chien YC; Ko JY; Jian JJ; Tsou YA; Leu YS; Liao LJ; Chang YL; Wang CP; Wu JS; Hua CH; Lee JC; Yang TL; Hsiao CK; Wu MS; Tsai MH; Huang KK; Yu K; Jones K; Zhu B; Yeager M; Yu G; Lou PJ; Chen CJ; Hildesheim A;
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1682-1686. PubMed ID: 31270100
[TBL] [Abstract][Full Text] [Related]
34. The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.
Tsang CM; Tsao SW
Virol Sin; 2015 Apr; 30(2):107-21. PubMed ID: 25910483
[TBL] [Abstract][Full Text] [Related]
35. Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.
Church TM; Verma D; Thompson J; Swaminathan S
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263273
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr Virus-Based Nasopharyngeal Carcinoma (NPC) Risk Prediction Scores Are Elevated in NPC Multiplex Family Members in Taiwan.
Lee MH; Huang YH; Coghill AE; Liu Z; Yu KJ; Hsu WL; Chien YC; Wang CP; Chen TC; Chen CJ; Hildesheim A
J Infect Dis; 2021 Feb; 223(3):441-444. PubMed ID: 32614957
[TBL] [Abstract][Full Text] [Related]
37. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; van de Loo RJM; de Jong R; Moelans CB; de Bree R; de Herdt MJ; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
Head Neck; 2018 Sep; 40(9):1986-1998. PubMed ID: 29927011
[TBL] [Abstract][Full Text] [Related]
38. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
[TBL] [Abstract][Full Text] [Related]
39. The role of microRNAs in nasopharyngeal carcinoma.
Tan G; Tang X; Tang F
Tumour Biol; 2015 Jan; 36(1):69-79. PubMed ID: 25427638
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]